Skip to main content
Have a personal or library account? Click to login
Deferred versus Expedited Aortic Valve Replacement in Patients with Symptomatic Severe Aortic Stenosis During the SARS-CoV-2 Pandemic (AS DEFER): A Research Letter Cover

Deferred versus Expedited Aortic Valve Replacement in Patients with Symptomatic Severe Aortic Stenosis During the SARS-CoV-2 Pandemic (AS DEFER): A Research Letter

Global Heart
Volume 16 (2021): Issue 1
By: Jonas Lanz,  Christoph Ryffel,  Noé Corpataux,  Nicole Reusser,  Taishi Okuno,  Bettina Langhammer,  David Reineke,  Fabien Praz,  Stefan Stortecky,  Stephan Windecker and  Thomas Pilgrim  
Open Access
|Apr 2021
Figures & tables

Figures & Tables

Figure 1

Pre-specified treatment strategy allocation algorithm and cumulative event curves for the primary composite endpoint of all-cause death, stroke and hospitalization for congestive heart failure (CHF). The crosses mark the time points of aortic valve replacement (AVR) in patients who crossed over to expedited AVR.

DOI: https://doi.org/10.5334/gh.989 | Journal eISSN: 2211-8179
Journal RSS Feed
Language: English
Submitted on: Jan 11, 2021
Accepted on: Apr 20, 2021
Published on: Apr 30, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
COVID-19,
aortic valve stenosis,
aortic valve replacement,
transcatheter aortic valve implantation

© 2021 Jonas Lanz, Christoph Ryffel, Noé Corpataux, Nicole Reusser, Taishi Okuno, Bettina Langhammer, David Reineke, Fabien Praz, Stefan Stortecky, Stephan Windecker, Thomas Pilgrim, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 16 (2021): Issue 1
Previous article
Next article